Skip to content

Triprolidine

Published: July 26, 2026Updated: August 26, 2026

Triprolidine is a first-generation antihistamine that provides relief from allergy symptoms by blocking histamine H1 receptors. It is commonly used to treat seasonal allergies, allergic rhinitis, and cold symptoms such as sneezing, runny nose, and itchy eyes.

Quick summary

A sedating antihistamine used to relieve allergic symptoms like sneezing, itching, and runny nose.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 26, 2026Editorial policy

Key facts at a glance

ATC
R06AX07
RxNorm
10811
Generic
Triprolidine
Class
atc-r06
Brands
Wal-Act, A-Phedrin, Aphedrid, Genac brand of pseudoephedrine/triprolidine, Pediaclear Childrens, Vi-Sudo, Flonase Nighttime
Availability
otc
Pregnancy
C
Lactation
caution
Half-life (h)
4
Onset (min)
30
Duration (h)
6
Routes
oral
Forms
tablet, film-coated tablet, syrup, oral solution
Regions
United States, Canada, United Kingdom, Australia, New Zealand, Ireland, South Africa
Monitoring
sedation, anticholinergic effects

This page is for informational purposes only.

Do not use this information to diagnose yourself or to replace a physician's advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. If you believe you are experiencing a medical emergency, call your local emergency number immediately.

Dosage and administration

adult (standard)tablet
Usual dose
2.5mg-5mg
Maximum
consult physician
Frequency
every 4-6 hours as needed
Instructions
Follow physician instructions
Duration limits
as prescribed
Monitoring
standard
pediatric (standard)tablet
Usual dose
1.25mg-2.5mg
Maximum
consult physician
Frequency
every 4-6 hours as needed
Instructions
Follow physician instructions
Duration limits
as prescribed
Monitoring
standard
geriatric (standard)tablet
Usual dose
2.5mg
Maximum
consult physician
Frequency
every 4-6 hours as needed
Instructions
Follow physician instructions
Duration limits
as prescribed
Monitoring
standard

Overdose information

Important overdose information
Toxic dose: Doses exceeding 75mg in adults may cause significant toxicity; pediatric exposures particularly dangerous
Chronic overdose: Prolonged use exceeding recommended doses may lead to cumulative anticholinergic effects and CNS toxicity
Immediate actions
Activated charcoal within 1-2 hours of ingestion if patient is awake and able to protect airway; gastric lavage rarely indicated; supportive care
Antidote
No specific antidote exists; treatment is supportive(N/A - supportive care only)
Poison Control: 1-800-222-1222

Special Populations

10 groups
⚠

pregnancy

first trimester
caution
FDA Category
C
Dose Adjustment

avoid if possible

Key Recommendations

use only if benefits outweigh potential risks to fetus

Monitor

regular prenatal monitoring

Use with caution and monitor for adverse effects.

⚠

pregnancy

second trimester
caution
FDA Category
C
Dose Adjustment

use lowest effective dose

Key Recommendations

use only if clearly needed

Monitor

standard prenatal care

Use with caution and monitor for adverse effects.

⚠

pregnancy

third trimester
caution
FDA Category
C
Dose Adjustment

avoid close to delivery

Key Recommendations

avoid use near term due to potential effects on newborn

Monitor

fetal monitoring in late pregnancy

Use with caution and monitor for adverse effects.

⚠

lactation

breastfeeding
caution
FDA Category
N
Dose Adjustment

avoid or use lowest dose

Key Recommendations

drug passes into breast milk, monitor infant for sedation

Monitor

observe infant for excessive drowsiness

Use with caution and monitor for adverse effects.

⚠

geriatric

elderly
caution
FDA Category
N
Dose Adjustment

reduce dose, start low

Key Recommendations

increased sensitivity to anticholinergic effects, risk of falls and confusion

Monitor

monitor for anticholinergic effects, cognitive changes

Use with caution and monitor for adverse effects.

✗

pediatric_age

infants and toddlers
contraindicated
FDA Category
N
Dose Adjustment

not recommended

Key Recommendations

do not use in children under 2 years due to risk of respiratory depression

Monitor

emergency medical attention if respiratory distress occurs

Use of this medication in this population requires careful consideration of risks and benefits.

⚠

pediatric_age

children
caution
FDA Category
N
Dose Adjustment

weight-based dosing, do not exceed recommended

Key Recommendations

use with caution in children 2-12 years, avoid in asthma

Monitor

monitor for paradoxical excitement or sedation

Use with caution and monitor for adverse effects.

⚠

renal_impairment

mild to moderate
caution
FDA Category
N
Dose Adjustment

may need dose reduction

Key Recommendations

use with caution, monitor for increased sedation

Monitor

monitor renal function and drug response

Use with caution and monitor for adverse effects.

⚠

hepatic_impairment

moderate
caution
FDA Category
N
Dose Adjustment

reduce dose

Key Recommendations

use with caution due to reduced metabolism

Monitor

monitor liver function and clinical response

Use with caution and monitor for adverse effects.

✗

alcohol_users

concurrent use
contraindicated
FDA Category
N
Dose Adjustment

avoid combination

Key Recommendations

do not consume alcohol with triprolidine

Monitor

none - avoid completely

Use of this medication in this population requires careful consideration of risks and benefits.

Statistics and clinical data

drug_classWHO
2023

Drug class

Value:First-generation antihistamine (ethanolamine derivative)

Triprolidine belongs to the ethanolamine class of first-generation H1 antihistamines

usageFDA
2023

Common uses

Value:Treatment of allergic rhinitis and common cold symptoms

Triprolidine is used as an antihistamine for relief of sneezing, runny nose, and watery eyes

prescribingFDA
2023

Commonly prescribed since

Value:1950s

Triprolidine has been on the market for over 70 years

formulationFDA
2023

Typical formulation

Value:Combination with pseudoephedrine

Triprolidine is commonly formulated in combination products with pseudoephedrine (decongestant) for cold and allergy relief

Relief of symptoms associated with allergic conditions including hay fever, allergic rhinitis, urticaria (hives), and common cold symptoms such as sneezing and runny nose. Often combined with decongestants for enhanced symptom relief.

Blocks histamine H1 receptors in the body, preventing histamine from binding and causing allergic responses. This reduces symptoms like itching, sneezing, nasal discharge, and watery eyes. It has anticholinergic properties that also help dry respiratory secretions.

May cause drowsiness and should be used with caution when driving or operating machinery. Alcohol and other CNS depressants may enhance sedation. Should be avoided in patients with narrow-angle glaucoma, urinary retention, or severe hypertension. Consult a healthcare provider before use during pregnancy or breastfeeding.

Contraindications

Conditions and patient states where this medication should be avoided or used with caution.

Do not use (1)

ABSOLUTEhypersensitivity

Known allergy to this medication or its components

Use caution (1)

RELATIVEpregnancy

Consult healthcare provider for benefits vs risks assessment

Official drug label

WellAlly may earn a referral fee from linked resources at no extra cost to you. Editorial content is never influenced by commercial relationships.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 26, 2026. · Read our editorial policy